MX2019014955A - Agente para prevenir o tratar enfermedades asociadas a tejido adiposo y/o inflamacion. - Google Patents

Agente para prevenir o tratar enfermedades asociadas a tejido adiposo y/o inflamacion.

Info

Publication number
MX2019014955A
MX2019014955A MX2019014955A MX2019014955A MX2019014955A MX 2019014955 A MX2019014955 A MX 2019014955A MX 2019014955 A MX2019014955 A MX 2019014955A MX 2019014955 A MX2019014955 A MX 2019014955A MX 2019014955 A MX2019014955 A MX 2019014955A
Authority
MX
Mexico
Prior art keywords
fat
prevention
agent
treatment
inflammation
Prior art date
Application number
MX2019014955A
Other languages
English (en)
Inventor
Kessoku Takaomi
Nakajima Atsushi
Ohno Hiroshi
Kawahara Tomohiro
Tanaka Yoshiki
Shimakawa Masaki
Original Assignee
Biofermin Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biofermin Pharmaceutical Co Ltd filed Critical Biofermin Pharmaceutical Co Ltd
Publication of MX2019014955A publication Critical patent/MX2019014955A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Un objeto de la presente invención es proporcionar un agente para prevenir o tratar una enfermedad asociada a tejido adiposo y/o inflamación. La presente invención proporciona un agente para prevenir o tratar una enfermedad asociada a tejido adiposo y/o inflamación, el agente comprende una bacteria Faecalibacterium o un producto procesado de la misma.
MX2019014955A 2017-06-16 2018-06-15 Agente para prevenir o tratar enfermedades asociadas a tejido adiposo y/o inflamacion. MX2019014955A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017118686 2017-06-16
PCT/JP2018/022865 WO2018230695A1 (ja) 2017-06-16 2018-06-15 脂肪関連疾患及び／又は炎症の予防又は治療剤

Publications (1)

Publication Number Publication Date
MX2019014955A true MX2019014955A (es) 2020-02-19

Family

ID=64660925

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019014955A MX2019014955A (es) 2017-06-16 2018-06-15 Agente para prevenir o tratar enfermedades asociadas a tejido adiposo y/o inflamacion.

Country Status (9)

Country Link
US (1) US11224622B2 (es)
EP (1) EP3639833B1 (es)
JP (1) JP7016085B2 (es)
CN (1) CN111107860A (es)
BR (1) BR112019025948A2 (es)
MX (1) MX2019014955A (es)
MY (1) MY201921A (es)
TW (1) TWI778083B (es)
WO (1) WO2018230695A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102169795B1 (ko) * 2020-06-24 2020-10-27 주식회사 엔테로바이옴 신규한 피칼리박테리움 프로스니치 eb-fpdk9 균주 및 그의 용도
KR102169794B1 (ko) * 2020-06-24 2020-10-27 주식회사 엔테로바이옴 신규한 피칼리박테리움 프로스니치 균주 eb-fpdk11 및 그의 용도
KR102185828B1 (ko) 2020-08-26 2020-12-03 주식회사 엔테로바이옴 피칼리박테리움 프로스니치 균주를 포함하는 아토피성 질환 예방 또는 치료용 약학적 조성물
CN115212237B (zh) * 2021-06-21 2023-11-17 上海大学 普拉梭菌在制备治疗心肌梗死后的心室病理性重构和/或心力衰竭的药物中的应用
CN115074276B (zh) * 2022-06-24 2024-01-02 无锡特殊食品与营养健康研究院有限公司 一株能够缓解非酒精性脂肪肝的普拉梭菌及其应用
CN115093999B (zh) * 2022-06-24 2023-10-27 江南大学 一株可改善血脂紊乱的普拉梭菌及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9700586B2 (en) * 2012-02-28 2017-07-11 Cornell University Probiotic compositions and methods
CN104540962B (zh) * 2012-08-01 2017-09-19 深圳华大基因研究院 糖尿病生物标志物及其应用
JP2016511272A (ja) * 2013-03-05 2016-04-14 レイクスユニフェルシテイト フローニンゲン 炎症を抑制するためのフィーカリバクテリウム・パラウスニッチィーｈｔｆ−ｆ（ｄｓｍ２６９４３）の使用
AU2014239883B2 (en) 2013-03-14 2019-01-17 Therabiome, Llc Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
WO2016065279A1 (en) 2014-10-23 2016-04-28 Symbiotic Health Inc. A capsule for the oral administration of biopharmaceuticals
JP2018515426A (ja) 2015-03-12 2018-06-14 ザ ユニヴァーシティ オブ ブリティッシュ コロンビア 細菌組成物およびその使用方法
GB201519088D0 (en) * 2015-10-28 2015-12-09 Metabogen Ab The use of bacteria formulations
FR3046934B1 (fr) * 2016-01-25 2018-01-26 Institut National De La Recherche Agronomique (Inra) Souche de faecalibacterium prausnitzii cncm i-4573 pour le traitement et la prevention d'une inflammation gastro-intestinale
JP2019520340A (ja) * 2016-06-01 2019-07-18 クレストヴォ・ホールディングス・エルエルシー 炎症性腸疾患（ｉｂｄ）および他の障害を治療するための組成物および方法
CN111246870B (zh) * 2017-06-02 2022-08-12 古德盖特公司 用于治疗生态失调的葡萄皮
CN115074276B (zh) * 2022-06-24 2024-01-02 无锡特殊食品与营养健康研究院有限公司 一株能够缓解非酒精性脂肪肝的普拉梭菌及其应用

Also Published As

Publication number Publication date
CN111107860A (zh) 2020-05-05
EP3639833A4 (en) 2021-03-10
MY201921A (en) 2024-03-23
EP3639833A1 (en) 2020-04-22
US11224622B2 (en) 2022-01-18
JPWO2018230695A1 (ja) 2020-03-26
TWI778083B (zh) 2022-09-21
US20210145897A1 (en) 2021-05-20
EP3639833B1 (en) 2023-08-09
WO2018230695A1 (ja) 2018-12-20
BR112019025948A2 (pt) 2020-06-30
JP7016085B2 (ja) 2022-02-21
TW201906619A (zh) 2019-02-16

Similar Documents

Publication Publication Date Title
MX2019014955A (es) Agente para prevenir o tratar enfermedades asociadas a tejido adiposo y/o inflamacion.
MX2018005600A (es) Composiciones farmaceuticas y metodos para la inhibicion de indolamina 2,3-dioxigenasa e indicaciones para ello.
PH12017500629A1 (en) Immuniregulatory agents
PH12017500604A1 (en) Immunoregulatory agents
MD3600364T2 (ro) Compoziții care conţin tulpină bacteriană din genul Megasphaera și utilizări ale acestora
MX2018002962A (es) Compuestos para el tratamiento de enfermedades relacionadas con la produccion de especies de oxigeno reactivo (eor) mitocondrial.
MX2017005462A (es) Agentes inmunorreguladores.
MX2016015610A (es) Agentes inmunorreguladores.
EP4252851A3 (en) Ezh2 inhibitors for treating lymphoma
SG10201908028SA (en) Cyclopropylamines as lsd1 inhibitors
BR112015026307A2 (pt) heterociclo bicíclicos como inibidores de fgfr
MX2016002075A (es) Inhibidores de indolamina 2,3-dioxigenasa (ido).
MX2017004618A (es) Inhibidores de la biosintesis de sulfato de heparano para el tratamiento de enfermedades.
MX2020005567A (es) Metodos de tratamiento con asparaginasa.
PH12019550265A1 (en) Composition comprising mannose oligosaccharide and process for making same and use thereof
MX2021007260A (es) Inhibidores de la vía de cinasa janus 1 (jak1) para el tratamiento de enfermedades gastrointestinales.
EP3685838A4 (en) COMPOSITION FOR THE TREATMENT OR PREVENTION OF OBESITY OR DISEASES RELATED TO OBESITY AND USE THEREOF
EP3865140A8 (en) Preventive and/or therapeutic agent for clostridium difficile infection
MX2022015456A (es) Composiciones de maca y metodos de uso.
MX2018011101A (es) Composiciones farmaceuticas para el tratamiento del cancer.
PH12019501999A1 (en) Pyrazole derivatives as bromodomain inhibitors
PH12020551331A1 (en) Treatment and prevention of pre-eclampsia
WO2020109233A3 (en) Trmt2a inhibitors for use in the treatment of polyglutamine diseases
PH12017501694A1 (en) Compositions for the treatment of fibrosis and fibrosis-related diseases
WO2018183494A8 (en) CONJUGATES ANTIBODY-DRUG TARGETED CD19